IL-7 R alpha Protein - ACROBiosystems

Home
Products

Products by Category

Recombinant proteins and more
Multi-pass Transmembrane Proteins and Technology PlatformsNew FDA DMF Filed ProteinsHot SARS-CoV-2 Related ProductsHot Immune Checkpoint ProteinsHot Targets of CAR-T Cell TherapyNew CytokinesHot Biosimilar Drug TargetsHot Tumor MicroenvironmentHot Anti-idiotypic AntibodyHot Fc Receptor Proteins Llama IgG Fc Fusion ProteinNew Bio-Markers & CD Antigens ActiveMax -Best Cytokines Viral Proteins Enzymes Antibodies All Recombinant Proteins

Pre-labeled proteins
CAR rapid detection reagentsNew Biotinylated protein collectionHot FITC & PE labeled ProteinsNew Fluorescent fusion proteins
Kits
SARS-CoV-2 Related Kit ProductsNew Pre-Coupling Magnetic BeadsNew ELISA Assay Kits for Quantitative Analysis of Therapeutic Antibodies in Serum Samples Inhibitor Screening Kits
Others
HPLC-verified Proteins Integrin - Integrin Proteins BCMA - B-Cell Maturation Antigen TIGIT - TIGIT Signaling Axis CD24 & Siglec-10 proteinsHot

Hot Products

Supports on COVID-19 R&D
Reagents for vaccine developmentNew Reagents for diagnostic developmentNew SARS-CoV-2 related productsNew SARS-CoV-2 related kitsNew SARS-CoV-2 mutant productsNew
Others
Multi-pass Transmembrane Proteins and Technology PlatformsNew Claudin18.2 ProteinsNew Bispecific antibody targetsHot Targets for ADCsHot IL-2 ReceptorsHot CD19 proteinsHot Anti-FMC63 mAbHot CD3 proteinsHot B7 family proteinsHot TNFSF proteinsHot VEGF proteinsHot CD39/CD73 proteinsNew Siglec-15 proteinsHot CD20 proteinsExclusive PD1 proteinsHot
Services

Innovation Lab
SPR /BLI analytical serviceNew Anti-Idiotypic AntibodyNew Enzyme-Linked Immunosorbent Assay (ELISA) Service New
Licensing Opportunities
Anti-TIM-3 monoclonal antibody New Anti-LAG-3 monoclonal antibody New Target 4-1BB monoclonal antibody New
Supports

How to Order Shipping & Payments Global Distributors Testimonials Download Brochures Download COA
Applications

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
Company

About Us Join Us Contact Us
Activities

News Exhibitions Promotion
COVID-19 R&D ^New

IL-7 R alpha

Brief Information

Name:Interleukin-7 receptor subunit alpha
Target Synonym:Interleukin-7 receptor subunit alpha,CDw127,IL-7RA,IL-7 receptor subunit alpha,IL7R,Interleukin 7 Receptor,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Isoform H5-6,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subun

Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical


IL7-H5258	Human	Human IL-7 R alpha / CD127 Protein, Mouse IgG2a Fc Tag
IL7-H82F8	Human	Biotinylated Human IL-7 R alpha / CD127 Protein, Fc,Avitag™
ILA-H5258	Human	Human IL-7 R alpha / CD127 Protein, Fc Tag

Cat. No.

Species

Product Description

Structure

Purity

Feature

IL7-H5258

Human

Human IL-7 R alpha / CD127 Protein, Mouse IgG2a Fc Tag

IL7-H82F8

Human

Biotinylated Human IL-7 R alpha / CD127 Protein, Fc,Avitag™

ILA-H5258

Human

Human IL-7 R alpha / CD127 Protein, Fc Tag

Part of Bioactivity data

IL7-H5258-SPR

Captured Human IL-7 R alpha, Mouse IgG2a Fc Tag (Cat. No. IL7-H5258) on CM5 chip via anti-mouse antibodies surface can bind ActiveMax® Human IL-7, Tag Free (Cat. No. IL7-H4219) with an affinity constant of 13.3 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Protocol

IL7-H82F8-ELISA

Immobilized ActiveMax® Human IL-7, Tag Free (Cat. No. IL7-H4219) at 10 μg/mL (100 μL/well) can bind Biotinylated Human IL-7 R alpha, Fc,Avitag (Cat. No. IL7-H82F8) with a linear range of 139 ng/mL (QC tested).

Protocol

Synonym Name

IL7Ra,CD127

Background

Interleukin-7 receptor subunit alpha (IL7Ra) is also known as CD antigen CD127, which belongs to the type I cytokine receptor family and type 4 subfamily. IL7Ra /CD127 contains 1 fibronectin type-III domain. IL7Ra /CD127 is expressed on various cell types, including naive and memory T cells and many others. IL7Ra /CD127 is receptor for interleukin-7 and also acts as a receptor for thymic stromal lymphopoietin (TSLP). The IL7 receptor is a heterodimer of IL7R and IL2RG. The TSLP receptor is a heterodimer of CRLF2 and IL7R.

Clinical and Translational Updates

Related Molecule

Clinical Drug Information

Name	Research Code	Research Phase	Company	Indications	Clinical Trials
GSK-2618960	GSK-2618960	Phase 2 Clinical	Glaxosmithkline Plc	Multiple Sclerosis, Relapsing-Remitting; Autoimmune Diseases; Sjogren's Syndrome	Details
BNT-152	BNT-152	Phase 1 Clinical	Biontech Se	Solid tumours	Details
OSE-127	OSE-127; S-95011	Phase 2 Clinical	Effimune	Sjogren's Syndrome; Colitis, Ulcerative; Inflammation	Details
Interleukin-7 (Revimmune SAS)	rhIL-7; CYT-107; CYT-99-007	Phase 2 Clinical	Cytheris	Mycobacterium Infections, Nontuberculous; Melanoma; Leukemia, Myeloid, Acute; Colorectal Neoplasms; Hepatitis C; Lymphopenia; Prostatic Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; HIV Infections; Myeloproliferative Disorders; Coronavirus Disease 2019 (COVID-19); Sepsis; Hepatitis B, Chronic; Shock, Septic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Kidney Neoplasms	Details
Efineptakin alfa (Genexine/NeoImmuneTech)	GX-I7; TJ-107; NT-I7	Phase 2 Clinical	Genexine Inc	Solid tumours; Carcinoma, Merkel Cell; Glioblastoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Coronavirus Disease 2019 (COVID-19); Papillomavirus Infections; Brain Neoplasms; Colorectal Neoplasms; Cervical Intraepithelial Neoplasia; Carcinoma, Squamous Cell; Glioma; Carcinoma, Non-Small-Cell Lung; Melanoma	Details